retatrutide fda approval timeline Status 2026: Everything We Know So Far What Is Retatrutide? New Weight

New or worsening depression, agitation, unusual behavior, or self-harm thoughts should be addressed immediately

Novo believes longer-acting agents could help patients stay on their medications

However, this raises concerns about budget sustainability and whether the federal government will need to step in to negotiate lower prices

10.3390/cancers14112719 176 WangX.ZhangH.ChenX

GLP-1 medications, on the other hand, may not be appropriate for people with a personal or family history of medullary thyroid carcinoma or MEN2, a history of pancreatitis, severe gastrointestinal conditions like gastroparesis, or anyone pregnant or breastfeeding